1299312-97-2 Usage
Uses
Used in Organic Synthesis:
5-bromo-6-methoxypyridin-3-ol is used as a building block in the creation of various functionalized pyridine derivatives. Its unique structure and reactivity make it valuable for developing a wide range of chemical compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 5-bromo-6-methoxypyridin-3-ol is utilized for the development of drugs and pharmaceuticals. Its potential antioxidant and anti-inflammatory properties are of particular interest, as these characteristics can contribute to the effectiveness of medications targeting a variety of health conditions.
Used in Chemical Industry:
5-bromo-6-methoxypyridin-3-ol's structural features and reactivity also make it a key component in the chemical industry, where it can be employed to produce a diverse array of products with specific applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1299312-97-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,9,9,3,1 and 2 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1299312-97:
(9*1)+(8*2)+(7*9)+(6*9)+(5*3)+(4*1)+(3*2)+(2*9)+(1*7)=192
192 % 10 = 2
So 1299312-97-2 is a valid CAS Registry Number.
InChI:InChI=1S/C6H6BrNO2/c1-10-6-5(7)2-4(9)3-8-6/h2-3,9H,1H3
1299312-97-2Relevant articles and documents
SUBSTITUTED TRIAZINONES AS THYROID HORMONE RECEPTOR AGONISTS
-
Paragraph 00329; 00332, (2021/07/24)
The application relates to a compound of Formula (I') or (I), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of thyroid hormone receptors, a pharmaceutical composition comprising a compound of Formula (I') or (I), and a method of treating or preventing a disease or disorder regulated by thyroid hormone.
2-AMINOINDOLE COMPOUNDS AND METHODS FOR THE TREATMENT OF MALARIA
-
Page/Page column 94, (2011/05/11)
The present invention relates to methods of treating a subject with malaria comprising administering a 2-aminoindole compound represented by Formula: (I)- The values and preferred values of the variables in Structural Formula I are defined herein.